No Benefit From RAI After Second Thyroid Cancer Surgery

Rodrigo Arrangoiz MS, MD, FACS, FSSO

Adding a course of radioactive iodine (RAI) to a second surgery for recurrent or persistent papillary thyroid carcinoma (PTC) does not appear to offer a clinical benefit, and there is no reduction in the rate of subsequent recurrences, conclude US researchers.

Their conclusions come from a retrospective analysis of just over 100 patients who underwent reoperation for recurrent PTC.

The study showed that patients experienced reductions in levels of tumor markers whether or not they underwent RAI administration. There was no significant difference in recurrence rates between the two groups.

However, the study also found there were fewer recurrences among patients who underwent surgery alone compared to those who also received RAI therapy, and RAI recipients were less likely to have an excellent tumor marker response.

The study was published online August 15 in JAMA Surgery.

Study author Michael W. Yeh, MD, Section of Endocrine Surgery, David Geffen School of Medicine, University of California, Los Angeles (UCLA), said that “for many years, radioactive iodine was thought to be just a freebie, that you got it and there were almost no side effects.”

 

El entrenamiento de Rodrigo Arrangoiz MS, MD, FACS experto en tumores de tiroides fue el siguiente:

• Cirugia general y gastrointestinal:

• Michigan State University:

• 2004 al 2010

• Cirugia oncológica / tumores de cabeza y cuello / cirugia endocrina:

• Fox Chase Cancer Center (Filadelfia):

• 2010 al 2012

• Maestria en ciencias (Clinical research for health professionals):

• Drexel University (Filadelfia):

• 2010 al 2012

• Cirugia de tumores de cabeza y cuello / cirugia endocrina

• IFHNOS / Memorial Sloan Kettering Cancer Center:

• 2014 al 2016

https://www.medscape.com/viewarticle/900880?src=WNL_recnl_180820_MSCPEDIT_hmonc&uac=112600CX&impID=1717418&faf=1#vp_1

Unknown's avatar

Published by Rodrigo Arrangoiz MS, MD, FACS, FSSO

My name is Rodrigo Arrangoiz I am a breast surgeon/ thyroid surgeon / parathyroid surgeon / head and neck surgeon / surgical oncologist that works at Center for Advanced Surgical Oncology in Miami, Florida. I was trained as a surgeon at Michigan State University from (2005 to 2010) where I was a chief resident in 2010. My surgical oncology and head and neck training was performed at the Fox Chase Cancer Center in Philadelphia from 2010 to 2012. At the same time I underwent a masters in science (Clinical research for health professionals) at the University of Drexel. Through the International Federation of Head and Neck Societies / Memorial Sloan Kettering Cancer Center I performed a two year head and neck surgery and oncology / endocrine fellowship that ended in 2016. Mi nombre es Rodrigo Arrangoiz, soy cirujano oncólogo / cirujano de tumores de cabeza y cuello / cirujano endocrino que trabaja Center for Advanced Surgical Oncology en Miami, Florida. Fui entrenado como cirujano en Michigan State University (2005 a 2010 ) donde fui jefe de residentes en 2010. Mi formación en oncología quirúrgica y e n tumores de cabeza y cuello se realizó en el Fox Chase Cancer Center en Filadelfia de 2010 a 2012. Al mismo tiempo, me sometí a una maestría en ciencias (investigación clínica para profesionales de la salud) en la Universidad de Drexel. A través de la Federación Internacional de Sociedades de Cabeza y Cuello / Memorial Sloan Kettering Cancer Center realicé una sub especialidad en cirugía de cabeza y cuello / cirugia endocrina de dos años que terminó en 2016.

Leave a comment